Crossmark

Efficacy of EZH2 inhibitory drugs in human papillomavirus-positive and human papillomavirus-negative oropharyngeal squamous cell carcinomas

Crossref DOI link: https://doi.org/10.1186/s13148-017-0390-y

Published Online: 2017-09-06

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lindsay, Cameron D.

Kostiuk, Morris A.

Harris, Jeff

O’Connell, Daniel A.

Seikaly, Hadi

Biron, Vincent L. http://orcid.org/0000-0002-7661-5277
Funding

Funding for this research was provided by:

University Hospital Foundation

Alberta Center for Head and Neck Oncology and Reconstruction